Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
33 /100
MEDIUM RISK
Score updated Oct 13, 2026

RGNT — Regentis Biomaterials Ltd. Dilution Risk Tracker

Track RGNT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RGNT — Get alerts when the score changes →

As of October 13, 2026, Regentis Biomaterials Ltd. (RGNT) has a DilutionWatch DilutionScore of 33/100, rated MEDIUM dilution risk. Regentis Biomaterials Ltd. has a market capitalization of $8.44M, 5.18M shares outstanding, 3 institutional holders tracked. Stored dilution-related fields include 11.3K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
42
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for RGNT.
🔔 Track RGNT — Get forecast alerts →

Market Data

Market Cap$8.44M
Shares Outstanding5.18M
Float2.82M
Cash$7.38M
Debt$1.20M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore33/100DilutionWatch score record
Shares Outstanding5.18MVerified float table or market cache
Public Float2.82MVerified float table or market cache
Market Cap$8.44MMarket data cache
Cash Runway64.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants11.3KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 3 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 96.4% shares (2026Q1 vs prior)
3 institutional holders · 551.8K shares
#1 AIGH Capital Management LLC 300.0K shares
#2 Rosalind Advisors, Inc. 251.5K shares
#3 UBS Group AG 334 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.8K
Days to Cover1.0
% of Float0.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-02-27
xbrl XBRL CONVERTIBLE 2026-02-27
3 FORM3 2026-03-30
3 FORM3 2026-03-18
3 FORM3 2026-03-18
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual RGNT Dilution Snapshot

Regentis Biomaterials Ltd. (RGNT) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

RGNT's DilutionScore is currently 33/100 (Medium risk), with 3 score changes tracked over 89 days. The score deteriorated from 36/100 (Medium risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202633/100MEDIUM16 days
Aug 22 – Sep 27, 202636/100MEDIUM37 days
Jul 17 – Aug 21, 202637/100MEDIUM35 days
Jul 16, 202639/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

RGNT shares outstanding have decreased 0.0% from 5.18M (Apr 2026) to 5.18M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 20265.18M2.82M▲ 4.60%
May 03, 20265.18M2.70M▼ 10.01%
Apr 07, 20265.18M3.00M▼ 4.12%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track RGNT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment RGNT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking RGNT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RGNT
RGNT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.